For decades, the United States has grappled with the complexities of chronic kidney disease and the plight of the almost ...

Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia HELSINKI, 12 March 2026 - Aplagon, a ...

VentureMed Group, Inc., an innovative medical device company specializing in vessel preparation and access management for AV ...

VentureMed Group, Inc. announced it is now doing business as (DBA) Flex Vascular. The medical device company specializes in ...

Aplagon has dosed the first patient in its phase 2a HEALING clinical trial evaluating APAC, a first‑in‑class treatment for thrombo‑inflammatory diseases, in people with peripheral arterial occlusive ...

Dialysis cases among Social Security Organi­sa­tion (PERKESO) contributors are rising steadily, with the number increasing by about 12% each year.

There is a particular kind of clarity that comes with watching a surgeon describe their work. Not the technical vocabulary, but the reasoning behind it. Sitting across from Dr. Shobhit Gupta at his ...

An inquest at Oxford Coroner's Court heard how a man who died at the John Radcliffe Hospital in Oxford suffered 'unsurvivable ...